Logo image of JNVR

JANOVER INC (JNVR) Stock Fundamental Analysis

NASDAQ:JNVR - Nasdaq - US47100L2025 - Common Stock

5.5  +0.29 (+5.57%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to JNVR. JNVR was compared to 53 industry peers in the Consumer Finance industry. No worries on liquidiy or solvency for JNVR as it has an excellent financial health rating, but there are worries on the profitability. JNVR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year JNVR has reported negative net income.
In the past year JNVR has reported a negative cash flow from operations.
JNVR Yearly Net Income VS EBIT VS OCF VS FCFJNVR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -1M -2M -3M

1.2 Ratios

JNVR has a worse Return On Assets (-76.21%) than 98.08% of its industry peers.
Looking at the Return On Equity, with a value of -86.40%, JNVR is doing worse than 94.23% of the companies in the same industry.
Industry RankSector Rank
ROA -76.21%
ROE -86.4%
ROIC N/A
ROA(3y)-77.2%
ROA(5y)N/A
ROE(3y)-227.15%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JNVR Yearly ROA, ROE, ROICJNVR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -100 -200 -300

1.3 Margins

JNVR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
JNVR Yearly Profit, Operating, Gross MarginsJNVR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -50 -100 -150

9

2. Health

2.1 Basic Checks

JNVR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JNVR has been reduced compared to 1 year ago.
JNVR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
JNVR Yearly Shares OutstandingJNVR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M
JNVR Yearly Total Debt VS Total AssetsJNVR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2M 4M 6M

2.2 Solvency

JNVR has an Altman-Z score of 66.30. This indicates that JNVR is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 66.30, JNVR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
There is no outstanding debt for JNVR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 66.3
ROIC/WACCN/A
WACC9.25%
JNVR Yearly LT Debt VS Equity VS FCFJNVR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M 4M

2.3 Liquidity

A Current Ratio of 8.89 indicates that JNVR has no problem at all paying its short term obligations.
JNVR has a Current ratio of 8.89. This is amongst the best in the industry. JNVR outperforms 92.31% of its industry peers.
A Quick Ratio of 8.89 indicates that JNVR has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 8.89, JNVR belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.89
Quick Ratio 8.89
JNVR Yearly Current Assets VS Current LiabilitesJNVR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1M 2M 3M 4M 5M

1

3. Growth

3.1 Past

The earnings per share for JNVR have decreased strongly by -685.52% in the last year.
The Revenue for JNVR has decreased by -13.70% in the past year. This is quite bad
The Revenue has been growing by 8.69% on average over the past years. This is quite good.
EPS 1Y (TTM)-685.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-97.92%
Revenue 1Y (TTM)-13.7%
Revenue growth 3Y8.69%
Revenue growth 5YN/A
Sales Q2Q%6.67%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JNVR Yearly Revenue VS EstimatesJNVR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 500K 1M 1.5M 2M
JNVR Yearly EPS VS EstimatesJNVR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

JNVR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JNVR Price Earnings VS Forward Price EarningsJNVR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JNVR Per share dataJNVR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

JNVR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

JANOVER INC

NASDAQ:JNVR (1/17/2025, 8:10:26 PM)

5.5

+0.29 (+5.57%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.14%
Inst Owner Change0%
Ins Owners53.34%
Ins Owner Change1.15%
Market Cap62.20M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 34.16
P/FCF N/A
P/OCF N/A
P/B 15.72
P/tB 21.91
EV/EBITDA N/A
EPS(TTM)-1.73
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS0.16
BVpS0.35
TBVpS0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -76.21%
ROE -86.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-77.2%
ROA(5y)N/A
ROE(3y)-227.15%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 19.94%
Cap/Sales 1.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.89
Quick Ratio 8.89
Altman-Z 66.3
F-Score4
WACC9.25%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-685.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-97.92%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.7%
Revenue growth 3Y8.69%
Revenue growth 5YN/A
Sales Q2Q%6.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-52.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-463.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-457.03%
OCF growth 3YN/A
OCF growth 5YN/A